Genetics and Cancer: Research Offers New Insights On Risks, Onset, Progression

School of Biological Sciences’ research tests widely-held medical hypothesis

Contact

Renay San Miguel
Communications Officer
College of Sciences
404-894-5209

 

Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

School of Biological Sciences’ research tests widely-held medical hypothesis

Full Summary:

A new study from the School of Biological Sciences raises questions about the chances for cancer to develop in human cells. The research, led by Professor John McDonald, is testing a widely-held hypothesis that involves how many mutations in tumor-suppressing genes are needed for the onset and development of the disease.

Media
  • A dying cancer cell with filopodia stretched out to its right. The protrusions help cancer migrate. Stock NIH NCMIR image. The image does not display a cell treated in the Georgia Tech study. Credit: NIH-funded image of HeLa cell / National Center for Mic A dying cancer cell with filopodia stretched out to its right. The protrusions help cancer migrate. Stock NIH NCMIR image. The image does not display a cell treated in the Georgia Tech study. Credit: NIH-funded image of HeLa cell / National Center for Mic
    (image/jpeg)
  • Cancer associated mutations were identified in the 1000 genomes population (1KGP.) Cancer associated mutations were identified in the 1000 genomes population (1KGP.)
    (image/jpeg)
  • John McDonald, professor in the School of Biological Sciences and director of the Integrated Cancer Research Center. John McDonald, professor in the School of Biological Sciences and director of the Integrated Cancer Research Center.
    (image/jpeg)

A new study by researchers in the School of Biological Sciences raises new questions about a decades-old, award-winning theory regarding how many genetic mutations are necessary for cancer to develop in human cells.

That theory, called the Knudson Hypothesis, argued that two mutations in the type of genes that suppress tumors are needed to lead to changes that could cause cancer. However, John McDonald, a School of Biological Sciences professor and the director of Georgia Tech’s Integrated Cancer Research Center, says the research, published in Oncotarget, “shows, for the first time, that nearly all normal healthy individuals carry at least one potentially cancer-causing tumor suppressor gene mutation. The implication is that a majority of the human population is, to a greater or lesser extent, predisposed to develop cancer.”

McDonald and his fellow researchers — Evan A. Clayton, Shareef Khalid, Dongjo Ban, Lu Wang and Professor I. King Jordan, all of Georgia Tech — relied on several databases, including the Catalogue of Somatic Mutations in Cancer (COSMIC), the world’s largest database of mutations associated with cancer onset and progression. The scientists combined that database with the One Thousand Genomes Project (1KGP), which lists genetic variants present, in 2,504 normal, healthy individuals. That list reflects the diversity of racial and ethnic groups randomly selected from 26 human populations around the world.

The Knudson Hypothesis, developed in 1971 by Alfred Knudson, helped physicians identify cancer-related genes, and won Knudson the prestigious Albert Lasker Award in Clinical Medical Research in 1998.

“Inconsistent with the Knudson two-hit hypothesis, we present evidence that acquisition of a second cancer-causing tumor suppressor mutation is not necessary to drive cancer onset/progression. Rather, we present evidence that, in many cases, individuals with only a single cancer-causing tumor suppressor mutation develop cancer,” McDonald says. “In these individuals, we show that the mutant gene is significantly overexpressed relative to the normal gene, thus overriding the influence of the non-mutated gene and driving cancer onset and development. Thus, in many individuals, a change in gene expression, rather than a ‘second mutational hit,’ is responsible for the cancer.”

All humans have two copies of every gene, each copy supplied by a biological parent. Two classes of genes are believed to cause the onset and progression of cancer. Oncogenes are genes that can drive cancer after a single mutation in one of the copies of the gene. In other words, those mutations are said to be “dominant” with respect to their ability to result in cancer.

Unlike oncogenes, a second class of cancer-driving genes, called tumor suppressor genes, are considered to be recessive. Knudson’s hypothesis took the point of view that mutations in each of the two copies of the tumor suppressor genes had to happen in order to drive cancer development. McDonald says the hypothesis is still widely held in 2020 by the cancer community.

“We believe that our findings are of major significance and call into question many of the assumptions underlying current methods to diagnose and treat cancer based on genomic profiling,” McDonald says.

This research was supported by the Ovarian Cancer Institute (Atlanta), Northside Hospital (Atlanta), the Deborah Nash Endowment Fund, and National Institute of Health Bioinformatics Training Grant: CRP 10-2012-03.

Additional Information

Groups

College of Sciences, School of Biological Sciences, Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Categories
Life Sciences and Biology
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
go-PetitInstitute, College of Sciences, School of Biological Sciences, John McDonald, Integrated Cancer Research Center, oncogenes, cancer, Genetics, genotypes, go-icrc, go-icrc-news
Status
  • Created By: Renay San Miguel
  • Workflow Status: Published
  • Created On: Feb 18, 2020 - 11:49am
  • Last Updated: Feb 24, 2020 - 1:17pm